Picard Medical Class Action Deadline Set for April 2026 Amid Securities Fraud Claims

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Picard Medical faces securities fraud class action over misleading statements and stock promotion in 2025. Investors must file claims by April 3, 2026.

Picard Medical Class Action Deadline Set for April 2026 Amid Securities Fraud Claims

Levi & Korsinsky has filed a class action securities lawsuit against Picard Medical, Inc., alleging the company engaged in a coordinated scheme to defraud investors through materially misleading statements and social media-driven stock promotion during a two-month period in 2025. The complaint covers alleged misconduct occurring between September 2, 2025 and October 31, 2025, and identifies insider share dumping as a component of the fraudulent activity.

Investors who believe they sustained losses from Picard Medical securities during the alleged fraud period are required to file claims by April 3, 2026 to participate in the class action. The deadline applies to all investors meeting the class definition, regardless of whether they have already contacted the law firm.

The lawsuit represents one of several securities fraud actions targeting publicly traded companies. Investors with potential claims are advised to consult with legal counsel regarding eligibility and procedural requirements for participation in the class action.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 19

Related Coverage

GlobeNewswire Inc.

FSK Securities Fraud Lawsuit: Investors Sought for Class Action Over Misleading Statements

Schall Law Firm seeks $FSK investors for class action lawsuit alleging false statements on portfolio restructuring, valuations, and dividend strength between May 2024 and February 2026.

FSK
GlobeNewswire Inc.

Securities Fraud Investigations Target LKQ, Molina, MongoDB, and Power Solutions

Grabar Law Office investigates four companies for alleged securities fraud involving false statements about business performance, causing stock price inflation and investor losses.

MOHLKQMDB
GlobeNewswire Inc.

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

POET
GlobeNewswire Inc.

LakeShore Biopharma Faces Securities Probe Over Alleged Misleading Statements

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

LSBCF
GlobeNewswire Inc.

CCRN Under Investigation for Alleged Securities Violations

Schall Law Firm investigates Cross Country Healthcare ($CCRN) for alleged securities violations involving false statements or material disclosure failures to investors.

CCRN
GlobeNewswire Inc.

$POET Technologies Faces Securities Lawsuit Over Tax Status Disclosure Failures

Rosen Law Firm filed a securities class action against POET Technologies over alleged false statements regarding PFIC tax status and inadequate disclosure of negative tax implications for U.S. investors. Lead plaintiff deadline: June 29, 2026.

POET